Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENKORTEN for Moderate to Severe COVID-19
NCT04374032Phase 3Completed
- Sponsor
- Bosnalijek
- Start
- May 2020
- Primary completion
- Oct 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of tridecactide in coronavirus disease 2019 (COVID-19), sponsored by Bosnalijek. Started May 2020; status: completed.
02
Drugs
tridecactide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04374032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04374032.